David Mehalick - CEO and President, Director, 10%+ Owner at Coeptis Therapeutics Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CEO and President, Director, 10%+ Owner
Stock Symbol
COEP
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by David Mehalick since 8/16/2023

Holdings reported by David Mehalick for Coeptis Therapeutics Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 1.8M Nov 16, 2021 Direct

Transactions reported by David Mehalick for Coeptis Therapeutics Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership